Zeta Pharma Launches The Novel Diabetes Medicine In The Egyptian Market.

0
687

CAIRO, EGYPT, April 11, 2021 /EINPresswire.com/ – In the presence of a group of eminent Egyptian professors of internal medicine and endocrinology, a luxury hotel in Cairo witnessed the opening conference of “๐„๐ฆ๐ฉ๐š๐œ๐จ๐ณ๐š”, the latest type 2 diabetes drug containing the active ingredient (Empagliflozin) included. This molecule resembles a quantum leap in the treatment of type 2 diabetes and was recently produced by ๐™๐ž๐ญ๐š ๐๐ก๐š๐ซ๐ฆ๐š.

Recent scientific studies have shown that in addition to being highly effective in controlling blood sugar, this drug is also beneficial for the heart and reduces the incidence of cardiovascular deaths. It also provides kidney protection and helps with weight loss in diabetics.

A group of senior medical professionals from all Egyptian universities attended this event and gave valuable instruction to the patient on the best use of this medicine.

Prof. Sherif Hafez, professor of internal medicine and diabetes at Cairo University, confirmed the importance of tight blood sugar controls to avoid serious complications. He also stressed the need for early blood sugar control and recommended strict control of blood pressure and cholesterol levels.

Prof. Megahid Abu Al-Majd, professor of internal medicine and diabetes at Mansoura University, praised the leap in the treatment of diabetes with the emergence of empagliflozin, which protects the heart and kidneys and helps with weight loss.

In addition to the scientific and medical discussions, the โ€œ๐ก๐š๐ฒ๐š๐ญ๐š๐คโ€ health initiative by Zeta Pharma was launched at the conference, which aims to raise awareness of diabetes and support diabetics from all perspectives. It does so in the context of striving to be a pioneer in the treatment of diabetics by providing the Egyptian patient with the latest and highest quality medicines in line with the global drug market and by running patient support programs.

-๐€๐›๐จ๐ฎ๐ญ ๐™๐ž๐ญ๐š ๐๐ก๐š๐ซ๐ฆ๐š:
Zeta Pharma, an Egyptian company, started its business activities in the Egyptian market with Virus-C drugs in 2015 and actively participated in the national initiative “โ€ž ๐ฆ๐ข๐ฅ๐ฅ๐ข๐จ๐ง ๐ฌ๐ž๐ก๐š “. Since then, ๐™๐ž๐ญ๐š ๐๐ก๐š๐ซ๐ฆ๐š continued to provide essential drugs to the Egyptian patient, with a future portfolio of more than 150 drugs in various therapeutic classes.
๐™๐ž๐ญ๐š ๐๐ก๐š๐ซ๐ฆ๐š has set up its factory in accordance with the latest international industry standards and requirements and has taken great strides to qualify for European GMP accreditation.

-๐…๐จ๐ซ ๐ฆ๐จ๐ซ๐ž ๐ข๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž ๐ฏ๐ข๐ฌ๐ข๐ญ ๐จ๐ฎ๐ซ ๐ฐ๐ž๐›๐ฌ๐ข๐ญ๐ž: www.zetapharma.net

DR. Faris Salama |
Zeta Pharma
+20 102 222 8221
email us here
Visit us on social media:
Facebook
LinkedIn

You just read:

News provided by

April 11, 2021 at 5:32 pm GMT


ONE Presswire’s priority is source transparency. We don’t allow opaque clients, and our editors try to be careful about weeding out false and misleading content. As a user, if you see something that we missed, make us aware of it. Your help is welcome. ONE Presswire, everyone’s internet news Presswire โ„ข, seeks to define some of the boundaries that are reasonable in the world today. Please see our editorial guidelines for more information.

Submit your press release